https://www.frontiershealth.co/agenda
-
-
-
-
-
The Regulatory Awareness Workshop (RAW) focuses on the medical device regulatory landscape that arises to startups and SMEs in the digital health sector. The RAW helps developers of medical and health-related apps and software to understand the importance of considering the medical device regulatory framework in the digital health sector.
By using case studies, the following issues are explained:
• when medical software falls under the medical device directive
• how to classify medical device software
• which key regulatory standards are mandatory
• the impact of the new regulation (MDR) on medical device software
The workshop will include a presentation (1 hour) and a Q&A section (1 hour).
Read more
-
Meet awesome up-and-coming start-ups, which will make it through our selection process, hear from key investors about their funding strategies and engage with the Experts’ Q&A Panel.
Moderated by: Paolo Borella
Presentations by:
AMICOMED - Giangiacomo Rocco di Torrepadula, CEO & Co-Founder
Binnovate Digital Health Corp - Kirby Binayao, Founder
GAIA - Mario Weiss CEO & Founder
HeartWatch - Guido Magrin CEO & Co-Founder
Kaia - Konstantin Mehl Founder and CEO
Keleya Digital-Health Solutions - Victoria Engelhardt Co-Founder
Oviva - Kai Eberhardt CEO and Co-Founder
QoLware - Ying Huang Finance & Legal
Selfapy - Farina Schurzfeld Co-founder
Sleep.ai - Michiel Allessie CEO and Founder
TOMMI - Valentino Megale CEO and Co-Founder
Read more
-
Meet awesome up-and-coming start-ups, which will make it through our selection process, hear from key investors about their funding strategies and engage with the Experts’ Q&A Panel.
Moderated by: Martin Kelly
Presentations by:
Paginemediche - Marina Peluso, Content & Social Media Strategy
Baze - Philipp Schulte, CEO
D-EYE - Alberto Scarpa, CEO
Infermedica - Piotr Orzechowski, Co-Founder
INNOVITAS VITAE - Alessandro Scozzesi, CEO
Med Angel - Amin Zayani CEO & co-founder
Medicinisto - Guido Axmann, CEO & co-founder
MediLad - Lutz Haase, Business angel
Miamed - Benedikt Hochkirchen, co-CEO
Myontec Oy - Janne Pylväs, CEO
Sky Labs - Jack Lee, CEO
SYMPTOMA - Jama Nateqi, CEO
Diagnosia - Lukas Zinnagl, Founder and CEO
Read more
-
-
During the meetings, invited startups will have the opportunity to present ideas on how to solve key challenges that Patients, their Caregivers and Physicians are likely to face when living with Hypertension, Angina, and Coronary Heart Disease (CHD).
Please contact the Frontiers Team or Menarini delegates in the Community to get considered for invitation.
Read more
-
-
-
Enjoying awesome food and drinks in excellent company are conducive to great spirits and conversations. This is why you will not want to miss Frontiers Health’s delicious Networking Lunch Break, which informally brings together entrepreneurs, founders, investors, pharma, device makers and insurance executives.
Read more
-
-
Introduced by: Paul Tunnah
Discover how new pharmaceutical companies are re-inventing themselves as ‘digital first’ and how established players are reinventing themselves through Open Innovation, launching Proof of Concept initiatives with clearly defined business roadmaps and goals.
Read more
-
-
Moderated by: Marc Sluijs
The current fragmentation of the Digital Health landscape is a barrier to large scale adoption due to a) a lack of end-to-end solutions, b) a lack of large scale evidence and c) the lack of financial bandwidth to fund global Go-To-Market and be a stable long term partner. As digital health consolidation is emerging, we will explore different M&A strategies and their implications for the ecosystem with our panel of investors and (recently acquired) digital health companies. In particular, we will explore the 3 main scenarios for digital health M&A: 1) similar companies merging to create more scale, 2) complementary companies merging to create more complete solutions, and 3) acquisitions of digital health companies by players from other industries.
Read more
-
Moderated by: Frederic Llordachs
Payers and health insurers are playing an increasingly important role in the adoption of Health 2.0 solutions and the general development of the digital health industry in Europe and around the world. After all, they have the most to gain from increased prevention, performant disease management and generally speaking improved clinical and financial outcomes. This panel session, convening the most active health insurers in digital health, will discuss solutions that are designed to be implemented “by” or “through a partnership with” health insurers.
Read more
-
-
Digital Nutrition: enhancing people’s quality of life through Nutrition, Health and Wellness
Read more
-
-
1:1 meetings slot for start-up and accredited investors in dedicated lounge
Read more
-
A customer experience workshop
Over the last 10 years, the healthcare industry has gone through several attempts at transforming itself to keep up with the torrid pace of changes in technology and services happening in other industries. While some “digital first” pharma initiatives have achieved good results, the overall success record across the industry is mixed at best. Today, a convergence of motivated consumers collecting personal health data with medical grade wearables, along with advances in data sciences/AI, and startups launching new healthcare models, present real threats as well as tremendous opportunities to traditional healthcare business stakeholders. Intouch Solutions and Healthware have joined forces to show a way forward that seeks to identify opportunities for engagement with today's health consumers by creating and delivering highly valuable customer experiences that integrate the latest innovations in tech and data.
Read more
-
-
Moderated by: Nana Bit-Avragim
As medicine grows more specialized and data-driven, the need to rethink the current business of clinical trials becomes imperative. The Internet of Things and emerging technologies offer many undeniable advantages to becoming the “new norm”. At the same time, the health industry is moving to a new paradigm, Medical Affairs 2.0, where data mining combined with medical expertise are becoming critical for R&D and commercial counterparts and its role in product launch is getting strategically crucial.
Now, which challenges clinical trials business are facing today? Who are the new players in the clinical trial ecosystem? Can web reset clinical trials?
Leading experts in pharma, medicine, technology, digital health and a patients’ representative will search for answers and discuss how to reinvent and accelerate progress towards networked and patient-centric clinical trials ecosystem.
Read more
-
The Pfizer Healthcare Challenge Award Ceremony is open to all Frontiers attendees and Pfizer guests (entry 4:30 pm, program from 5:00 pm to 6.30 pm, closes in an networking aperitif).
Agenda
16:30 Entry for Pfizer guests and other conference attendees
17:00 Welcome by Pfizer Healthcare Hub, Moderation by Dr. Karsten Neumann (Roland Berger Spielfeld)
17:05 Keynote Peter Albiez, Country Manager Germany, Pfizer
17:15 Presentation of the Pfizer Healthcare Challenge 2017
17:30 Pitches of the finalists
17:50 Ceremony
18:00 Panel discussion with the winners & the jury
18:30 Ending & Networking Aperitif
Read more
-
-
Conference co-hosts Healthware International and Intouch Solutions are delighted to sponsor the Frontiers Health 2017 Networking Aperitif reception and welcome all speakers and delegates
- DAY TWO
-
-
-
The NHS is one of the leading health systems in the world. Learn how it is embracing digital health and hear about some of the recent pilots involving cutting edge digital health tools.
Read more
-
Data Science provides huge opportunities to improve healthcare, as well as private and public life. Unfortunately, such opportunities are also coupled to significant ethical challenges, involving privacy, trust, transparency, accountability, and responsibility. On the one hand, overlooking ethical issues may prompt negative impact and social rejection. On the other hand, overemphasizing these issues may lead to regulations that are too rigid, and this in turn can cripple the potential of AI in data driven health applications. In this talk, I will focus on Digital Ethics, as the right macroethical framework for harnessing the values of data science in healthcare while respecting human rights and societal values.
Read more
-
-
Founders and Directors of well established innovative companies talk about their transition from startups to fast-growing businesses. Learn from these game changers’ success stories, discover future strategies and, with the sentiment pointing towards more M&As, will we witness the next major acquisition unfolding before our very eyes? Leading investors will egange the presenters with in-depth conversations to reveal the dynamics of these successful and fast growing companies.
Introduced by: Unity Stoakes
Company Presentations: Antidote, Ayogo Health, HealthLoop, Owlstone Medical, SkinVision.
Experts: Janke J. Dittmer, Min-Sung Sean Kim, Edward Kliphuis, Mauro Pretolani, Richard Willmot, Francesca Domenech Wuttke.
Read more
-
-
-
-
Pioppi is a tiny fishing village in the south of Italy that holds the secret to longevity and good health. Local residents often live to over 100 and remain active in their community during their golden and platinum years. In the 1950’s Pioppi became the location of a study on nutrition and longevity by note American Physiologist Ancel Keys, whose work became know worldwide as “The Mediterranean Diet”. Given today's stratospheric rise of metabolic diseases such as diabetes, hypertension and obesity, a team lead by noted British cardiologist Dr. Aseem Malhotra and documentary film maker Donal O’Neill went back to Pioppi to find out what, if anything, might have been missed by Professors Keys in his original assessment. Their work brings us The Pioppi Protocol, an alternative interpretation of the observations from Prof. Keys, and a scientifically informed guide for better nutrition, movement and lifestyle inspired by the habits of the people of Pioppi, and that is already beginning to show promising health results in the people following it. Today the Pioppi Protocol is available in a documentary and book (published by Penguin Books as the Pioppi Diet) and will shortly be launched as a software platform for adoption by insurance companies and wellness programs, along with a clinical study that has been designed to measure its effectiveness.
Read more
-
-
More than 150 companies are already working on digital therapeutics, and an increasing number of these are starting to show significant clinical evidence. In addition, several pharma companies have started investing in digital therapeutics companies, and are partnering to distribute digital therapeutics through their sales channels. This is a strong indication that digital therapeutics will be the "3rd wave of medicine". Our panel will discuss the resulting industry transformation, the opportunities for healthcare providers and the pharma industry, and what efforts are underway to define new protocols of care and measures of clinical effectiveness.
Read more
-
-
A new breed of disruptive digital innovators are moving to become the access point for healthcare to millions of patients as health care solutions become more consumer friendly offering convenience, affordability, accessibility, and in many cases better efficacy threatening to undermine the healthcare industry’s decades old model.
Rather than buying a pill, insurers or employers are purchasing entire solutions that embody sensors, mobile phone access, and big data driven intelligent virtual care from companies that have digital competence and the ability to build lasting bonds with consumers.
When upwards of 25% of all health spending including pharmaceuticals are not contributing to positive patient outcomes, how will the pharmaceutical industry move beyond the pill to embrace a “healthware” (healthcare and software) approach to delivering better outcomes, improving access, and lowering costs?
Read more
-
Data about healthcare and biometric data are considered 'sensitive data' under the General Data Protection Regulation of the European Union, which will come into full effect in May 2018. In principle, processing those data is prohibited, though there are exceptions. It is far from sure that smart healthcare applications will be covered by those exceptions. This will have an impact on digital health start-ups and hamper innovation in practice. In addition, the application of the GDPR is determined by the scope of 'personal data', which may include anonymous, aggregated and statistical data - this may have a big impact on the possibility of doing scientific medical research on patient data and biosamples. Although the privacy and data protection framework has not always been adequately enforced, the GDPR will change this - inter alia, it allows for fines running up to 20 million euro's when the rules are not respected. This may happen when there is no explicit informed consent for scientific research using patients health data, not giving patients full control over their own tissues or when there are insufficient safeguards to ensure that the data that are used of patients are correct and up to date.
Read more
-
-
The rise and adoption of MusicMedicine can be compared to those of Acupuncture, but on a much faster scale! Practitioners of this innovative health practice select specific types of music to address their patients’ different health needs with the same attention as if choosing and prescribing actual medicines. This talk will balance the practical and theoretical aspects of MusicMedicine.
Read more
-
-
To wrap-up Frontiers Health 2017 experts from the different corners of the digital health ecosystem will answer fast paced questions to address what a possible roadmap could be for the upcoming year and which priorities are arising on the medium / long term horizon. This will be the final highlight of our program and the seed for the 2018 edition
Read more
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.